Emmessar Biotech & Nutrition Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 0.63 | 0.70 | 0.53 |
| Operating Expense | 0.37 | 0.42 | 0.38 |
| Net Profit | 0.17 | -0.07 | 0.02 |
| Net Profit Margin | 26.98 | -10.00 | 3.77 |
| Earning Per Share | 0.34 | -0.16 | 0.03 |
| EBIDTA | 0.25 | 0.29 | 0.01 |
| Effective Tax Rate | 23.08 | 121.43 | -20 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 0.63 |
| Operating Expense | 0.37 |
| Net Profit | 0.17 |
| Net Profit Margin | 26.98 |
| Earning Per Share | 0.34 |
| EBIDTA | 0.25 |
| Effective Tax Rate | 23.08 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 0.61 | 0.56 | 1.02 |
| Operating Expenses Annual | 1.56 | 1.64 | 1.71 |
| Operating Profit Annual | 1.06 | 0.91 | 1.06 |
| Interest Annual | 0.00 | TBA | TBA |
| Depreciation | 0.10 | 0.10 | 0.09 |
| Net Profit Annual | 0.32 | 0.75 | 0.50 |
| Tax Annual | 0.64 | 0.06 | 0.46 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 0.61 |
| Operating Expenses Annual | 1.56 |
| Operating Profit Annual | 1.06 |
| Interest Annual | 0.00 |
| Depreciation | 0.10 |
| Net Profit Annual | 0.32 |
| Tax Annual | 0.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.01 | 0.01 | 0.18 |
| Cash Flow from Operations | 0.22 | 0.64 | 0.38 |
| Cash Flow from Investing | -0.23 | -0.64 | -0.55 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 0.01 | 0.01 | 0.01 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.01 |
| Cash Flow from Operations | 0.22 |
| Cash Flow from Investing | -0.23 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 173.77 | 162.50 | 103.92 |
| PBIT Margin (%) | 157.38 | 144.64 | 95.10 |
| PBT Margin (%) | 157.38 | 144.64 | 95.10 |
| Net PROFIT Margin (%) | 52.46 | 133.93 | 49.02 |
| Return On Networth / Equity (%) | 4.23 | 10.65 | 7.79 |
| Return On Networth /Employed (%) | 11.52 | 10.31 | 13.37 |
| Return On Assets (%) | 3.67 | 9.38 | 6.86 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.07 | 0.07 | 0.14 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 173.77 |
| PBIT Margin (%) | 157.38 |
| PBT Margin (%) | 157.38 |
| Net PROFIT Margin (%) | 52.46 |
| Return On Networth / Equity (%) | 4.23 |
| Return On Networth /Employed (%) | 11.52 |
| Return On Assets (%) | 3.67 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1.22 | 1.31 | 1.40 |
| Total Current Assets Annual | 7.41 | 6.83 | 5.93 |
| Non Current Assets Annual | 1.81 | 1.91 | 2.01 |
| Total Shareholders Funds Annual | 7.71 | 7.40 | 6.66 |
| Total Assets Annual | 9.22 | 8.74 | 7.94 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1.22 |
| Total Current Assets Annual | 7.41 |
| Non Current Assets Annual | 1.81 |
| Total Shareholders Funds Annual | 7.71 |
| Total Assets Annual | 9.22 |
No Data Availabe
